Systemic arterial pressure response to two weeks of Tempol therapy in SHR: Involvement of NO, the RAS, and oxidative stress

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 288, Issue 4 57-4, 2005, Pages

  Yanes, Licy ^a   Romero, Damian ^a   Iliescu, Radu ^a   Cucchiarelli, Valeria E ^a   Fortepiani, Lourdes A ^a   Santacruz, Francisco ^b   Bell, William ^a   Zhang, Huimin ^a   Reckelhoff, Jane F ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Department of Physiopathology   (Paraguay)

Author keywords

Antioxidant; Nitric oxide; Renin angiotensin system; Superoxide

Indexed keywords

ANGIOTENSIN; ANTIOXIDANT; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; RENIN; SUPEROXIDE; TEMPOL;

ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DEPRESSOR RESPONSE; DRUG EFFECT; ENDOTHELIUM INJURY; ENZYME INHIBITION; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; URINE LEVEL; VASCULAR ENDOTHELIUM;

ACRIDINES; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CYCLIC N-OXIDES; DINOPROST; ENZYME INHIBITORS; HYPERTENSION; LUMINESCENT MEASUREMENTS; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RENIN; RENIN-ANGIOTENSIN SYSTEM; SPIN LABELS; SUPEROXIDES;

EID: 15544370549     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00530.2004     Document Type: Article

References (31)

1. Ascherio A, Rimm EB, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ, and Willett WC. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 130: 963-970, 1999.
2. Cuzzocrea S, Mazzon E, Dugo L, Di Paola R, Caputi AP, and Salvemini D. Superoxide: a key player in hypertension. FASEB J 18: 94-101, 2004.
3. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr T, and Malinski T. Role of superoxide in the depressed nitric oxide production by endothelium of genetically hypertensive rats. Hypertension 26: 854-857, 1995.
4. Kagiyama S, Tsuchihashi T, Abe I, Matsumura K, and Fujishima M. Central infusion of L-arginine or superoxide dismutase does not alter arterial pressure in SHR. Hypertens Res 23: 339-343, 2000.
5. Kumar DV and Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 19: 59-66, 1993.
6. Lacy F, O'Conner DT, and Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensive and normotensive subjects at genetic risk of hypertension. J Hypertens 16: 291-303, 1998.
7. Lahera V, Salom MG, Miranda-Guardiola F, Moncada S, and Romero JC. Effects of N-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol Renal Fluid Electrolyte Physiol 261: F1033-F1037, 1991.
8. Lohmeier TE, Mizelle HL, Reinhart GA, and Montani JP. Influence of angiotensin on the early progression of heart failure. Am J Physiol Regul Integr Comp Physiol 278: R74-R86, 2000.
9. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
10. Maffei A, Poulet R, Vecchione C, Colella S, Fratta L, Frati G, Trimarco V, Trimarco B, and Lembo G. Increased basal nitric oxide release despite enhanced free radical production in hypertension. J Hypertens 20: 1135-1142, 2002.
11. Marchioli R, Schweiger C, Levantesi G, Tavazzi L, and Valagussa F. Antioxidant vitamins and prevention of cardiovascular disease: epidemiology and clinical trial data. Lipids 36: S53-S63, 2001.
12. Pryor WA and Squadrito GL. Chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol Lung Cell Mol Physiol 268: L699-L722, 1995.
13. Reckelhoff JF, Kellum JA, Blanchard EJ, Bacon EE, Wesley AJ, and Kruckeberg WC. Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. Life Sci 24: 1895-1902, 1994.
14. Reckelhoff JF and Manning RD Jr. Role of endothelium-derived nitric oxide in control of renal microvasculature in aging male rats. Am J Physiol Regul Integr Comp Physiol 265: R1126-R1131, 1993.
15. Reckelhoff JF, Zhang H, and Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats. Role of the renin-angiotensin system. Hypertension 35: 480-483, 2000.
16. 2-isoprostanes in rats. Hypertension 35: 476-479, 2000.
17. Rice-Evans C and Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 234: 279-293, 1994.
18. Schnackenberg CG, Tabor BL, Strong MH, and Granger JP. Inhibition of intrarenal nitric oxide stimulates renin secretion through a macula densa-mediated mechanism. Am J Physiol Regul Integr Comp Physiol 272: R879-R886, 1997.
19. Schnackenberg CG, Welch WJ, and Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 12: 59-64, 1998.
20. Shastri S, Gopalakrishnan V, Poduri R, and Di Wang H. Tempol selectively attenuates angiotensin II-evoked vasoconstrictor responses in spontaneously hypertensive rats. J Hypertens 20: 1381-1391, 2002.
21. Shohogi T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, and Abe Y. Renal sympathetic nerve responses to Tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
22. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematsu M, Zweifach BW, and Schmid-Schonbein GW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 95: 4754-4759, 1998.
23. Suzuki H, Swei A, Zweifach BW, and Schmid-Schonbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension 25: 1083-1089, 1995.
24. Thorup C and Persson AE. Impaired effect of nitric oxide synthesis inhibition on tubuloglomerular feedback in hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 271: F246-F252, 1996.
25. Tse WY, Maxwell SR, Thomason H, Blann A, Thorpe GH, Waite M, and Holder R. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J Hum Hypertens 8: 843-849, 1994.
26. Vidal MJ, Romero JC, and Van Houtte PM. Endothelial-derived relaxing factor inhibits renin release. Eur J Pharmacol 149: 401-402, 1988.
27. Welch WJ, Tojo A, Lee JU, Rang DG, Schnackenberg CG, and Wilcox CS. Nitric oxide synthase in the JGA of the SHR: expression and role of tubuloglomerular feedback. Am J Physiol Renal Physiol 277: F130-F138, 1999.
28. Wen Y, Killalea S, McGettigan P, and Freely J. Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients. Ir J Med Sci 165: 210-1212, 1996.
29. - in DOCA-salt rats. Hypertension 43: 329-334, 2004.
30. Zhou MS, Adam AG, Jaimes EA, and Raij L. In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension 42: 945-951, 2003.
31. Zhou MS, Jaimes EA, and Raij L. Atorvastatin prevents end-organ injury in salt-sensitive hypertension. Role of eNOS and oxidant stress. Hypertension 44: 186-190, 2004.